A phase II study of biomarker-driven early discontinuation of anti-PD-1 therapy in patients with advanced melanoma (PET-Stop): ECOG-ACRIN EA6192 Meeting Abstract
| Authors: | Gibney, G. T.; Lee, S. J.; Atkins, M. B.; Wong, T. Z.; Guerriero, J.; Marron, T. U.; Cohen, G. I.; Truong, T. G.; Carvajal, R. D.; Snyder, B.; Farwell, M.; Kirkwood, J. M.; Wolchok, J. D. |
| Abstract Title: | A phase II study of biomarker-driven early discontinuation of anti-PD-1 therapy in patients with advanced melanoma (PET-Stop): ECOG-ACRIN EA6192 |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680305147 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.TPS9591 |
| Notes: | Meeting Abstract: TPS9591 -- This meeting was also held virtually -- Source: Wos |
